富臨精工(300432.SZ):擬規劃新增投資年產25萬噸磷酸鐵鋰正極材料項目
格隆匯7月20日丨富臨精工(300432.SZ)公佈,公司於2021年7月20日召開第四屆董事會第十二次會議,審議通過《關於規劃新增投資年產25萬噸磷酸鐵鋰正極材料項目的議案》,公司子公司江西昇華新材料有限公司(“江西昇華”)擬規劃新增投資建設年產25萬噸磷酸鐵鋰正極材料項目,預計總投資40億元。
項目達產後,預計可實現税後年平均收入110.62億元,年平均淨利潤11億元。(市場價格波動存在不確定性)
鑑於新能源鋰電產業快速發展的趨勢及正極材料的行業格局,為了滿足核心客户對產品供應的需求,進一步優化磷酸鐵鋰正極材料產能布局,進一步擴大公司磷酸鐵鋰正極材料產品的市場規模,提升公司產能規模、持續盈利能力及綜合競爭實力。對公司提升並夯實在磷酸鐵鋰領域的行業地位具有積極意義,符合公司的整體發展戰略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.